Showing results (21-30 of 47) with videos related to
Sort By:
Pageof 5
Anaesthesia|April 8, 1999
Neuromuscular blocking effects and train-of-four fade with cisatracurium: comparison with other nondepolarising relaxantsM T Carroll, R K Mirakhur, D W Lowry, et al.Midwifery|April 11, 2022
The challenges and opportunities for implementing group antenatal care ('Pregnancy Circles') as part of standard NHS maternity care: A co-designed qualitative studyO Wiseman, L Emmett, G Hickford, et al.Scientific Reports|October 26, 2017
Ghrelin rescues skeletal muscle catabolic profile in the R6/2 mouse model of Huntington's diseaseMarie Sjögren, Ana I Duarte, Andrew C McCourt, et al.British Journal of Anaesthesia|October 28, 1999
Spontaneous or neostigmine-induced recovery after maintenance of neuromuscular block with Org 9487 (rapacuronium) or rocuronium following an initial dose of Org 9487K C McCourt, R K Mirakhur, D W Lowry, et al.Anesthesia and Analgesia|October 13, 1998
Neuromuscular effects of rocuronium during sevoflurane, isoflurane, and intravenous anesthesiaD W Lowry, R K Mirakhur, G J McCarthy, et al.Anaesthesia|April 4, 2001
Postoperative residual block after intermediate-acting neuromuscular blocking drugsA H Hayes, R K Mirakhur, D S Breslin, et al.Plos One|August 4, 2016
White Adipose Tissue Browning in the R6/2 Mouse Model of Huntington's DiseaseAndrew C McCourt, Lovisa Jakobsson, Sara Larsson, et al.Neuroscience|June 25, 2005
Transmitter content, origins and connections of axons in the spinal cord that possess the serotonin (5-hydroxytryptamine) 3 receptorD Conte, E D Legg, A C McCourt, et al.British Journal of Anaesthesia|February 26, 2000
Haemodynamic effects of rapacuronium in adults with coronary artery or valvular diseaseK C McCourt, P Elliott, R K Mirakhur, et al.Journal of Huntington'S Disease|July 27, 2014
Skeletal muscle atrophy in R6/2 mice - altered circulating skeletal muscle markers and gene expression profile changesAnna Magnusson-Lind, Marcus Davidsson, Edina Silajdžić, et al.Pageof 5